Advanced Cancer Treatments in China and Asia
We don't provide treatment, we open doors to access elite oncology centers in China and Asia, specializing in CAR-T, NK cells, TIL, and Gamma Delta T-cell therapies — backed by over 700 active clinical trials.
- Accurate initial medical evaluation within 48 hours by oncology experts
- Access coordination to exclusive public and private centers in China
- Comprehensive companion and support services in Arabic
- Full transparency: No fees for coordination services
Meet our medical team →
Your First Step Toward New Treatment Horizons
Accurate and free initial review with no obligation. Our medical team will study your case and return with a clear roadmap within 48 hours.
You're Not Alone in This Journey
Whatever your treatment stage, we're here to bridge you to the latest medical advances
For Those Seeking Hope
- Confirm diagnosis with international experts
- Review your treatment plan from top oncologists
- Explore advanced treatment options based on your case
For Those Seeking Latest Science
- Candidates for CAR-T cell therapy
- Immunotherapy options available in Asia
- Clinical trial matching across continents
For Those Seeking World-Class Care with Dignity
- Choose the right oncology center
- Medical visa assistance
- Travel and accommodation coordination
Compare Treatment Options
Evidence-based comparisons to help you make the right decision
CAR-T vs Chemotherapy
Compare efficacy, side effects, and costs between cellular therapy and traditional chemotherapy.
Read comparisonTIL vs Immunotherapy
Are tumor-infiltrating lymphocytes more effective than immune checkpoint inhibitors?
Read comparisonNK Cells vs CAR-T
Natural killer cells or modified T-cells: which is right for your case?
Read comparisonChina vs USA in Cellular Therapy
Comprehensive comparison: cost, wait times, clinical trials, and quality of care.
Read comparisonData and Insights
Facts and figures based on the latest studies to help you on your treatment journey
CAR-T Cost by Country
China: $30-80K | USA: $375-500K
Treatment Wait Time
China: 2-4 weeks | USA & Europe: 4-8 weeks
Active Clinical Trials
China leads the world in CAR-T and immunotherapy trials
Survival Rate Comparison
Improved survival with cellular therapy vs chemotherapy
Targeted Therapies We Coordinate Access To
Latest cellular immunotherapies backed by advanced clinical research
CAR-T Cell Therapy
Genetically modified T-cells targeting specific cancer antigens for blood cancers.
Source: ClinicalTrials.gov ↗
Gamma Delta T-Cells
Innate immune cells effective against solid tumors without HLA matching requirement.
Source: PubMed ↗
TIL Therapy
Tumor-infiltrating lymphocytes expanded to fight metastatic cancers.
Source: PubMed ↗
Natural Killer (NK) Cells
Natural killer cells providing innate immunity against cancer cells.
Source: PubMed ↗
Where Innovation Happens
Partner oncology centers in key medical destinations
How We Work
Treatment access coordination in 5 clear steps
Medical Records Review
Send medical reports for initial review. Response within 48 hours.
Matching the Right Oncology Center
We match your case with appropriate partner oncology centers.
Treatment Options Presentation
Receive detailed treatment proposals and transparent costs.
Admission and Ethics Approval
Official admission from the oncology center.
Treatment and Ongoing Support
Travel coordination, visa assistance, and non-medical support.
Why Choose CancerCareE
Our approach based on trust and science
Fully Transparent Process
Clear communication at every step with no hidden fees.
Global Oncology Center Network
Partnerships with accredited oncology centers in Europe, America, and Asia.
Dedicated Coordination Team
Personal coordinator assisting with all non-medical aspects.
Multi-Language Support
Coordination available in Arabic, English, Turkish, Russian, and Persian.
Cellular Therapy Specialization
Specialized expertise in CAR-T and cellular immunotherapies.
Clear and Transparent Role
We are access coordinators, not a hospital.
Leading Partner Oncology Specialists
Meet our partner medical team specialized in advanced treatments

Dr. Brian Liu
Specialist in CAR-T treatment for blood cancers and leading gene therapy approaches in China.
View Profile
Dr. Qian Li
Expert in CAR-T therapy for refractory blood disorders and stem cell transplantation in China.
View Profile
Dr. Yafei Wang
Leading specialist in multiple myeloma, lymphoma, leukemia, and advanced transplant techniques.
View ProfilePatient Stories
Real stories of patients who accessed advanced cancer treatments

After relapsing with 90% blast cells, CAR-T therapy in China achieved complete remission.
Traveled from Russia for neuroblastoma treatment — our comprehensive services made the journey smooth and successful.

Targeted CAR-T therapy in China gave new hope when conventional treatments failed.
Medical Library
Trusted educational content about advanced cancer treatments

What After Traditional Treatment Failure?
Understanding treatment pathways for patients who have exhausted conventional options.
Read Article
CAR-T and Cellular Therapy Basics
Comprehensive patient guide to cellular immunotherapies.
Read Article
Treatment Access Guides: Asia and Europe
Practical information for international patients.
Read ArticleFrequently Asked Questions
Common questions about treatment access coordination services
Our treatment access coordination services are completely free for patients.
We are treatment access coordinators, not treatment providers.
No, we cannot guarantee treatment outcomes or cures.
We aim to provide an initial response within 48 hours.
Yes. China leads the world with over 700 active CAR-T clinical trials.
For Hospitals, Physicians & Medical Partners
Are you an oncology center or medical specialist interested in partnering with us?
Learn About Partnership Opportunities